|
Vanguard FTSE All-World ex-US Index Fund ETF Shares | VEU | Vanguard European Stock Index Fund | VGK | SPDR® EURO STOXX 50 ETF | FEZ | United States Oil Fund, LP | USO | iShares MSCI Germany ETF | EWG | SPDR® S&P Emerging Markets Small Cap ETF | EWX | United States Natural Gas Fund, LP | UNG | iShares MSCI Australia ETF | EWA | iShares MSCI EAFE Small-Cap ETF | SCZ | iShares MSCI All Country Asia ex Japan ETF | AAXJ |
Gross Expense Ratio*
0.08%
SEC 30 Day Yield (as of 02/28/23 )
--
Ann. Dividend/Yield
$1.57/3.04%
Ex-Dividend Date
3/20/2023
52-Wk Range
43.06 - 58.82
Fund Inception
03/02/2007
|
 Loading...
The chart is currently unavailable.
|
The investment seeks to track the performance of a benchmark index that measures the investment return of stocks of companies located in developed and emerging markets outside of the United States.The fund employs an indexing investment approach designed to track the performance of the FTSE All-World ex US Index. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.
|
Market Return % (as of 02/28/2023) |
NAV Return % (as of 02/28/2023) |
Market Return % (as of 12/31/2022) |
NAV Return % (as of 12/31/2022) |
1-Month |
-4.39% |
-4.28% |
-2.19% |
-2.22% |
3-Month |
+1.65% |
+1.51% |
+14.43% |
+14.87% |
6-Month |
+7.42% |
+7.50% |
+2.16% |
+2.75% |
Year-to-date |
+3.93% |
+3.82% |
-15.59% |
-15.46% |
1-Year |
-7.29% |
-7.05% |
-15.59% |
-15.46% |
3-Year |
+5.37% |
+5.37% |
+0.52% |
+0.61% |
5-Year |
+1.97% |
+2.00% |
+1.20% |
+1.28% |
10-Year |
+4.24% |
+4.27% |
+3.95% |
+4.06% |
Since Inception |
+2.93% |
+3.06% |
+2.71% |
+2.85% |
Inception Date: March 02, 2007
Performance Details
Total return reflects performance without adjusting for sales charges or the effects of taxation, but is adjusted to reflect all actual ongoing fund expenses and assumes reinvestment of dividends and capital gains. If adjusted, sales charges would reduce the performance quoted. Performance data quoted represents past performance, is no guarantee of future results, and may not provide an adequate basis for evaluating the performance potential of the product over varying market conditions or economic cycles. Current performance may be higher or lower than the performance data quotes. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost.
|
Market Return % (as of 02/28/2023) |
NAV Return % (as of 02/28/2023) |
Market Return % (as of 12/31/2022) |
NAV Return % (as of 12/31/2022) |
1-Year |
-7.29% |
-7.05% |
-15.59% |
-15.46% |
5-Year |
+1.97% |
+2.00% |
+1.20% |
+1.28% |
10-Year |
+4.24% |
+4.27% |
+3.95% |
+4.06% |
Since Inception |
+2.93% |
+3.06% |
+2.71% |
+2.85% |
Inception Date: March 02, 2007
Cyclical |
43.75% |
8.36% |
11.36% |
21.22% |
2.81% |
Defensive |
19.70% |
7.16% |
9.51% |
3.03% |
Sensitive |
36.55% |
6.02% |
5.14% |
13.92% |
11.47% |
Portfolio Details
|
Company |
YTD Return (as of 03/24/2023) |
% of Assets |
* Tencent Holdings Ltd |
+19.61% |
1.11% |
* Taiwan Semiconductor Manufacturing Co Ltd |
-- |
1.05% |
* ASML Holding NV |
+18.31% |
1.04% |
* Samsung Electronics Co Ltd |
-- |
0.93% |
* Novo Nordisk A/S Class B |
+11.38% |
0.93% |
* Shell PLC |
-0.31% |
0.90% |
* LVMH Moet Hennessy Louis Vuitton SE |
+20.54% |
0.87% |
* Roche Holding AG |
-8.49% |
0.84% |
* AstraZeneca PLC |
+0.35% |
0.81% |
* Novartis AG |
-9.92% |
0.71% |
* represents an International company or one without a recognizable symbol.
Portfolio Details
|
|
|